Patent · US Expired

Spliced gene of KSHV/HHV8, its promoter and monoclonal antibodies specific for LANA2

US6866854B1 · kind B1 · utility

10Cited by
4References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 5, 2003
Grant dateMar 15, 2005
Priority date
Expiry dateSep 5, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/16422
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides an isolated nucleic acid which encodes a Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 2 polypeptide (LANA2) or a fragment thereof and also provides the LANA2 polypeptide. This invention provides an isolated nucleic acid comprising consecutive nucleotides having the sequence of a promoter of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 2 transcription. This invention also provides a method of inhibiting p53 mediated apoptosis of a cell and a method of producing an antibody which comprises introducing into a cell a replicable vector of the subject invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.